- Active not recruitingPHASE2, PHASE3
Management of Castration-Resistant Prostate Cancer with Oligometastases
This study looks at a new way to treat advanced prostate cancer that has spread to a few places. It tests if adding special radiation (SBRT) to standard hormone therapy can delay the cancer from getting worse and put off other treatments.
For: Castration-resistant Prostate Cancer Patients with OligometastasesCanada - Active not recruitingPHASE3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
This study looks at new ways to treat prostate cancer that hasn't spread but is at medium risk of doing so. It uses a gene test to decide if less or more intense treatment might be better, hoping to reduce side effects or improve outcomes.
For: Prostate AdenocarcinomaUnited States · Canada